Protective roles for potassium SK/Kca2 channels in microglia and neurons

Frontiers in Pharmacology

Volumn 3 NOV, Issue , 2012, Pages

  Dolga, Amalia M ^a   Culmsee, Carsten ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Calcium regulation; Kca2 SK channels; Kca3 IK channels; Microglia; Neuroprotection

Indexed keywords

ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; CALCIUM ION; CALMODULIN; CATION CHANNEL; CELL PROTEIN; CYPPA PROTEIN; DOPAMINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; POTASSIUM CHANNEL; POTASSIUM CHANNEL KCA2; POTASSIUM CHANNEL KCA2.2; POTASSIUM CHANNEL KCA2.3; POTASSIUM CHANNEL KCNN3; POTASSIUM CHANNEL SK2; POTASSIUM CHANNEL SK3; SMALL CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CARBOXY TERMINAL SEQUENCE; CELL ACTIVATION; CELL ACTIVITY; CELL PROTECTION; DOPAMINERGIC NERVE CELL; EXTRACELLULAR CALCIUM; HUMAN; INTRACELLULAR SIGNALING; MICROGLIA; NERVE CELL EXCITABILITY; NERVE CELL INHIBITION; NERVE CONDUCTION; NEUROMODULATION; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TARGETING;

EID: 84870763790     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2012.00196     Document Type: Article

References (100)

1. 2+-activated K+ channels: form and function. Annu. Rev. Physiol. 74, 245-269.
2. Allen, D., Nakayama, S., Kuroiwa, M., Nakano, T., Palmateer, J., Kosaka, Y., et al. (2011). SK2 channels are neuroprotective for ischemia-induced neuronal cell death. J. Cereb. Blood Flow Metab. 31, 2302-2312.
3. Arima, J., Matsumoto, N., Kishimoto, K., and Akaike, N. (2001). Spontaneous miniature outward currents in mechanically dissociated rat Meynert neurons. J. Physiol. 534, 99-107.
4. 2+-activated TRPM4-like currents (I CAN) in cultured mouse microglial cells. J. Physiol. 586, 427-439.
5. Benítez, B. A., Belálcazar, H. M., Anastasía, A., Mamah, D. T., Zorum-ski, C. F., Mascó, D. H., et al. (2011). Functional reduction of SK3-mediated currents precedes AMPA-receptor-mediated excito-toxicity in dopaminergic neurons. Neuropharmacology 60, 1176-1186.
6. 2+-activated K+ channel knock-out mice reveal the identity of calcium-dependent afterhyperpolarization currents. J. Neurosci. 24, 5301-5306
7. Bosch, M. A., Kelly, M. J., and Rønnekleiv, O. K. (2002). Distribution, neuronal colocalization, and 17beta-E2 modulation of small conductance calcium-activated K(+) channel (SK3) mRNA in the guinea pig brain. Endocrinology 143, 1097-1007.
8. 2+-dependent K+ channel, KCNN4/KCa3.1, improves tissue protection and locomotor recovery after spinal cord injury. J Neurosci. 31, 16298-16308.
9. Brähler, S., Kaistha, A., Schmidt, V. J., Wölfle, S. E., Busch, C., Kaistha, B. P., et al. (2009). Genetic deficit of SK3 and IK1 channels disrupts the endothelium-derived hyperpo-larizing factor vasodilator pathway and causes hypertension. Circulation 119,2323-2332.
10. Burdakov, D., Petersen, O. H., and Verkhratsky, A. (2005). Intralumi-nal calcium as a primary regulator of endoplasmic reticulum function. Cell Calcium 38, 303-310.
11. Cao, Y. J., Dreixler, J. C., Couey, J. J., and Houamed, K. M. (2002). Modulation of recombinant and native neuronal SK channels by the neu-roprotective drug riluzole. Eur. J. Pharmacol. 449, 47-54.
12. Chen, Y. J., Raman, G., Bodendiek, S., O'Donnell, M. E., and Wulff, H. (2011). The KCa3.1 blocker TRAM-34 reduces infarction and neurological deficit in a rat model of ischemia/reperfusion stroke. J. Cereb. Blood Flow Metab. 31, 2363-2374.
13. Coulon, P., Herr, D., Kanyshkova, T., Meuth, P., Budde, T., and Pape, H. C. (2009). Burst discharges in neurons of the thalamic reticular nucleus are shaped by calcium-induced calcium release. Cell Calcium 46, 333-346.
14. Cui, G., Okamoto, T., and Morikawa, H. (2004). Spontaneous opening of T-type Ca channels contributes to the irregular firing of dopamine neurons in neonatal rats. J. Neurosci. 24, 11079-11087.
15. Deignan, J., Luján, R., Bond, C., Riegel, A., Watanabe, M., Williams, J.T., et al. (2012). SK2 and SK3 expression differentially affect firing frequency and precision in dopamine neurons. Neuroscience 217, 67-76.
16. Dolga, A. M., Granic, I., Blank, T., Knaus, H. G., Spiess, J., Luiten, P. G., et al. (2008). TNF-alpha-mediates neuroprotection against glutamate-induced excitotoxicity via NF-kappaB-dependent up-regulation of K2.2 channels. J. Neurochem. 107, 1158-1167.
17. Dolga, A. M., Letsche, T., Gold, M., Doti, N., Bacher, M., Chiamvi-monvat, N., et al. (2012). Activation of KCNN3/SK3/K(Ca)2.3 channels attenuates enhanced calcium influx and inflammatory cytokine production in activated microglia. Glia 60, 2050-2064.
18. 2+]i deregulation and reduces neuronal death following glutamate toxicity and cerebral ischemia. Cell Death Dis. 2, e147.
19. Dunnett, S. B., and Bjorklund, A. (1999). Prospects for new restorative and neuroprotective treatments in Parkinson's disease. Nature 399, A32-A39.
20. Eder, C. (1998). Ion channels in microglia (brain macrophages). Am. J. Physiol. 275, C327-C342.
21. 2+ -activated K+ currents of ramified murine brain macrophages. Naunyn Schmiede-bergsArch. Pharmacol. 356,233-239.
22. Eriksen, B. L., Teuber, L., Hougaard, C., and Sørenson, U. S. (2006). Pyrazolyl-pyrimidines as potassium channel modulating agents and their medical use. Patent WO/2006/100212.
23. Faber, E. S., Delaney, A. J., and Sah, P. (2005). SK channels regulate excitatory synaptic transmission and plasticity in the lateral amygdala. Nat. Neurosci. 8, 635-644.
24. 2+-activated K+ (BK) channel inacti-vation contributes to spike broadening during repetitive firing in the rat lateral amygdala. J. Physiol. 552, 483-497.
25. Fakler, B., and Adelman, J. P. (2008). Control of KCa channels by calcium nano/microdomains. Neuron 59,873-881.
26. Fiorillo, C.D., and Williams, J.T. (1998). Glutamate mediates an inhibitory postsynaptic potential in dopamine neurons. Nature 394, 78-82.
27. Grace, A. A., and Bunney, B. S. (1984). The control of firing pattern in nigral dopamine neurons: burst firing. J. Neurosci. 4, 2877-2890.
28. Grace, A. A., and Onn, S. P. (1989). Morphology and electrophysiologi-cal properties of immunocytochem-ically identified rat dopamine neurons recorded in vitro. J. Neurosci. 9, 3463-3481.
29. Grenhoff, J., Ugedo, L., and Svensson, T. H. (1988). Firing patterns of midbrain dopamine neurons: differences between A9 andA10 cells. Acta Physiol. Scand. 134, 127-132.
30. Grunnet, M., Jespersen, T., Angelo, K., Frøkjaer-Jensen, C., Klaerke, D. A., Olesen,S.P.,et al. (2001).Pharmacological modulation of SK3 channels. Neuropharmacology 40, 879-887.
31. Gulledge, A. T., and Stuart, G. J. (2005). Cholinergic inhibition of neocorti-cal pyramidal neurons. J. Neurosci. 25,10308-10320.
32. Haddock, R. E., and Hill, C. E. (2002). Differential activation of ion channels by inositol 1,4,5-trisphosphate (IP3)- and ryanodine-sensitive calcium stores in rat basilar artery vasomotion. J. Physiol. (Lond.) 545, 615-627.
33. Hayashi, Y., Kawaji, K., Sun, L., Zhang, X., Koyano, K., Yokoyama, T., et al. (2011). Microglial Ca(2+)-activated K(+) channels are possible molecular targets for the analgesic effects of S-ketamine on neuropathic pain. J. Neurosci. 31, 17370-17382.
34. Herrik, K. F., Redrobe, J. P., Holst, D., Hougaard, C., Sandager-Nielsen, K., Nielsen, A. N., et al. (2012). CyPPA, a positive SK3/SK2 modulator, reduces activity of dopaminergic neurons, inhibits dopamine release, and counteracts hyper-dopaminergic behaviors induced by methylphenidate. Front. Pharmacol. 3:11.doi:10.3389/fphar.2012.00011
35. Hirsch, E. C., and Hunot, S. (2009). Neuroinflammation in Parkinson's disease: a target for neuroprotection? Lancet Neurol. 8, 382-397.
36. Hoffmann, A., Kann, O., Ohlemeyer, C., Hanisch, U. K., and Ketten-mann, H. (2003). Elevation of basal intracellular calcium as a central element in the activation of brain macrophages (microglia): suppression of receptor-evoked calcium signaling and control of release function. J. Neurosci. 23, 4410-4419.
37. 2+-activated K+ channels. Br. J. Pharmacol. 151, 655-665.
38. 2+ -activated K+ channels inhibit human pancreatic cancer cell growth in vitro. Mol. Pharmacol. 65, 630-638.
39. 2+ -activated K+ channel of intermediate conductance: a possible target for immune suppression. Expert Opin. Ther. Targets 6, 623-636.
40. Ji, H., Hougaard, C., Herrik, K. F., Strøbaek, D., Christophersen, P., and Shepard, P. D. (2009). Tuning the excitability of midbrain dopamine neurons by modulating the Ca2+ sensitivity of SK channels. Eur. J. Neurosci. 29, 1883-1895.
41. Judge, S. I., Smith, P. J., Stewart, P. E., and Bever, C. T. Jr. (2007). Potassium channel blockers and openers as CNS neurologic therapeutic agents. Recent Pat. CNS Drug Discov. 2, 200-228.
42. Kakizawa, S., Kishimoto, Y., Hashimoto, K., Miyazaki, T., Furutani, K., Shimizu, H., et al. (2007). Junctophilin-mediated channel crosstalk essential for cerebellar synaptic plasticity. EMBO J. 26, 1924-1933.
43. 2+-activated K+ channel KCNN4/KCa3.1 contributes to microglia activation and nitric oxide-dependent neu-rodegeneration. J. Neurosci. 27, 234-244.
44. Kettenmann, H., Hanisch, U. K., No da, M., and Verkhratsky, A. (2011). Physiology of microglia. Physiol. Rev. 91,461-553.
45. Khanna, R., Roy, L., Zhu, X., and Schlichter, L. C. (2001). K+ channels and the microglial respiratory burst. Am. J. Physiol. Cell Physiol. 280, C796-C806.
46. Klegeris, A., Choi, H. B., McLarnon, J. G., and McGeer, P. L. (2007). Functional ryanodine receptors are expressed by human microglia and THP-1 cells: their possible involvement in modulation of neu-rotoxicity. J. Neurosci. Res. 85, 2207-2215.
47. 2+-activated K+ currents and hyperpolarizations in rat medial preoptic neurons. J. Neurophysiol. 103,2900-2911.
48. Köhler, M., Hirschberg, B., Bond, C. T., Kinzie, J. M., Marrion, N. V., Maylie, J., et al. (1996). Small-conductance, calcium-activated potassium channels from mammalian brain. Science 273, 1709-1714.
49. Köhler, R., Kaistha, B. P., and Wulff, H. (2010). Vascular KCa-channels as therapeutic targets in hypertension and restenosis disease. Expert Opin. Ther. Targets 14, 143-155.
50. Köhler, R., Wulff, H., Eichler, I., Kneifel, M., Neumann, D., Knorr, A., et al. (2003). Blockade of the intermediate-conductance calcium-activated potassium channel as a new therapeutic strategy for restenosis. Circulation 108, 1119-1125.
51. Koistinaho, M., and Koistinaho, J. (2002). Role of p38 and p44/42 mitogen-activated protein kinases in microglia. Glia 40, 175-183.
52. Kuiper, E. F., Nelemans, A., Luiten, P., Nijholt, I., Dolga, A., and Eisel, U. (2012). K(Ca)2 and K(Ca)3 channels in learning and memory processes, and neurodegen-eration. Front. Pharmacol. 3:107. doi:10.3389/fphar.2012.00107
53. Kye, M. J., Spiess, J., and Blank, T. (2007). Transcriptional regulation of intronic calcium-activated potassium channel SK2 promoters by nuclear factor-kappa B and gluco-corticoids. Mol. Cell. Biochem. 300, 9-17.
54. 2+ -activated K+ channels. Proc. Natl. Acad. Sci. U.S.A. 108, 5946-5953.
55. Liégeois, J. F., Mercier, F., Graulich, A., Graulich-Lorge, F., Scuvée-Moreau, J., and Seutin, V. (2003). Modulation of small conductance calcium-activated potassium (SK) channels: a new challenge in medicinal chemistry. Curr. Med. Chem. 10, 625-647.
56. Liu, B. S., Ferreira, R., Lively, S., and Schlichter, L. C. (2012). Microglial SK3 and SK4 currents and activation state are modulated by the neu-roprotective drug, riluzole. J. Neu-roimmune Pharmacol. [Epub ahead of print].
57. Lu, Z. (2004). Mechanism of rectification in inward-rectifier K+ channels. Annu. Rev. Physiol. 66, 103-129.
58. Mattson, M. P. (2005). NF-kappaB in the survival and plasticity of neurons. Neurochem. Res. 30, 883-893.
59. Morikawa, H., Imani, F., Khodakhah, K., and Williams, J. T. (2000). Inositol 1,4,5-triphosphate-evoked responses in midbrain dopamine neurons. J. Neurosci. 20, RC103.
60. Nagano, T., Kimura, S. H., Takai, E., Matsuda, T., and Takemura, M. (2006). Lipopolysaccharide sensitizes microglia toward Ca(2+)-induced cell death: mode of cell death shifts from apoptosis to necrosis. Glia 53, 67-73.
61. 2+-mediated feedback loop in dendritic spines. Nat. Neurosci. 8, 642-649.
62. 2+ -activated K+ channels controls fast inhibitory synaptic transmission at auditory outer hair cells. Neuron 26,595-601.
63. Pedarzani, P., and Stocker, M. (2008). Molecular and cellular basis of small- and intermediate-conductance, calcium-activated potassium channel function in the brain. Cell. Mol. Life Sci. 65, 3196-3217.
64. 2+-activated K+ channels regulate pacemaker activity in nigral dopamine neurons. Neu-roreport 7,809-814.
65. Polazzi, E., and Monti, B. (2010). Microglia and neuroprotection: from in vitro studies to therapeutic applications. Prog. Neurobiol. 92, 293-315.
66. Power, J. M., and Sah, P. (2008). Competition between calcium-activated K+ channels determines cholin-ergic action on firing properties of basolateral amygdala projection neurons. J. Neurosci. 28, 3209-3220.
67. Qian, L., Flood, P. M., and Hong, J. S. (2010). Neuroinflammation is a key player in Parkinson's disease and a prime target for therapy. J. Neural Transm. 117,971-979.
68. Ristori, G., Romano, S., Visconti, A., Cannoni, S., Spadaro, M., Frontali, M., et al. (2010). Riluzole in cerebellar ataxia: a randomized, double-blind, placebo-controlled pilot trial. Neurology 74, 839-845.
69. Rupalla, K., Allegrini, P. R., Sauer, D., and Wiessner, C. (1998). Time course of microglia activation and apoptosis in various brain regions after permanent focal cerebral ischemia in mice. Acta Neuropathol. 96, 172-178.
70. 2+ ions in dendritic spines. Neuron 33,439-452.
71. 2+ -activated potassium channel subunits, SK1, SK2, and SK3 in mouse brain. Mol. Cell. Neurosci. 26, 458-469.
72. Sarpal, D., Koenig, J. I., Adelman, J. P., Brady, D., Prendeville, L. C., and Shepard, P. D. (2004). Regional distribution of SK3 mRNA-containing neurons in the adult and adolescent rat ventral midbrain and their relationship to dopamine-containing cells. Synapse 53, 104-113.
73. 2+ activated SK3 channel is expressed in microglia in the rat striatum and contributes to microglia-mediated neurotoxicity in vitro. J. Neuroinflammation 7, 4.
74. Seutin, V., Mkahli, F., Massotte, L., and Dresse, A. (2000). Calcium release from internal stores is required for the generation of spontaneous hyperpolarizations in dopaminergic neurons of neonatal rats. J. Neurophysiol. 83, 192-197.
75. Skaper, S. D. (2011). Ion channels on microglia: therapeutic targets for neuroprotection. CNS Neurol. Disord. Drug Targets 10, 44-56.
76. Sørensen, U. S., Teuber, L., Peters, D., Stroebaek, D., Johansen, T. H., Nielsen, K. S., et al. (2006a). Novel 2-amino benzimidalzole derivatives and their use as modulators of small conductance calcium-activated potassium channels. Patent WO/2006/074991.
77. Sørensen, U. S., Teuber, L., Peters, D., Stroebaek, D., Johansen, T. H., Nielsen, K. S., et al. (2006b). 2-(phenylamino)benzimidalzole derivatives and their use as mod ulators of small conductance calcium-activated potassium channels. Patent WO/2006/136580.
78. Spanagel, R., and Weiss, E (1999). The dopamine hypothesis of reward: past and current status. Trends Neurosci. 22,521-527.
79. + channels: molecular determinants and function of the SK family. Nat. Rev. Neurosci. 5. 758-770.
80. 2+ -activated K+ channels by the synthetic compound (R) -N- (benzimidazol-2-yl) -1,2,3,4-tetrahydro-1-naphtylamine (NS8593) reduces afterhyper-polarizing current in hippocampal CA1 neurons. Mol. Pharmacol. 70, 1771-1782.
81. 2+ -activated K+ channels by NS309 (6,7-dichloro-1H-indole-2,3-dione 3-oxime). Biochim. Biophys. Acta 1665, 1-5.
82. Svensson, T. H. (2000). Dysfunctional brain dopamine systems induced by psychotomimetic NMDA-receptor antagonists and the effects of antipsychotic drugs. Brain Res. Brain Res. Rev. 31, 320-329.
83. Tanabe, M., Mori, M., Gähwiler, B. H., and Gerber, U. (1999). Apamin-sensitive conductance mediates the K(+) current response during chemical ischemia in CA3 pyramidal cells. J. Neurophysiol. 82, 2876-2882.
84. Varas-Lorenzo, C., Riera-Guardia, N., Calingaert, B., Castellsague, J., Pari-ente, A., Scotti, L., et al. (2011). Stroke risk and NSAIDs: a systematic review of observational studies. Pharmacoepidemiol. Drug Saf. 20, 1225-1236.
85. Verkhratsky, A., and Kettenmann, H. (1996). Calcium signalling in glial cells. Trends Neurosci. 19, 346-352.
86. Virgili, N., Espinosa-Parrilla, J. F., Mancera, P., Pastén-Zamorano, A., Gimeno-Bayon, J., Rodríguez, M. J., et al. (2011). Oral administration of the KATP channel opener dia-zoxide ameliorates disease progression in a murine model of multiple sclerosis. J. Neuroinflammation 8, 149.
87. Walter, J. T., Alvina, K., Womack, M. D., Chevez, C., and Khodakhah, K. (2006). Decreases in the precision of Purkinje cell pace-making cause cerebellar dysfunction and ataxia. Nat. Neurosci. 9, 389-397.
88. Wang, X., Fulp, A. B., van Rhee, A. M., and Spear, K. L. (2003). Bis-benzimidazoles and related compounds as potassium channel modulators. Patent WO/2003/094861.
89. Waubant, E. (2007). Neuroprotection with riluzole in patients with early multiple sclerosis. Patent NCT00501943.
90. Whitton, P. S. (2010). Neuroinflammation and the prospects for anti-inflammatory treatment of Parkinson's disease. Curr. Opin. Investig Drugs 11, 788-794.
91. Wilson, C. J., Young, S. J., and Groves, P. M. (1977). Statistical properties of neuronal spike trains in the substantia nigra: cell types and their interactions. Brain Res. 136, 243-260.
92. Wolfart, J., Neuhoff, H., Franz, O., and Roeper, J. (2001). Differential expression of the small-conductance, calcium-activated potassium channel SK3 is critical for pacemaker control in dopaminergic midbrain neurons. J. Neurosci. 21, 3443-3456.
93. Wulff, H., Calabresi, P. A., Allie, R., Yun, S., Pennington, M., Beeton, C., et al. (2003). The voltage-gated Kv1.3 K+ channel in effector memory T cells as newtarget for MS. J. Clin. Invest. 111, 1703-1713.
94. Wulff, H., Kolski-Andreaco, A., Sankaranarayanan, A., Sabatier, J. M., and Shakkottai, V. (2007). Modulators of small- and intermediate-conductance calcium-activated potassium channels and their therapeutic indications. Curr. Med. Chem. 14, 1437-1457.
95. 2+-activated K+ channel, IKCa1: a potential immunosuppressant. Proc. Natl. Acad. Sci. U.S.A. 97, 8151-8156.
96. Wyss-Coray, T., and Mucke, L. (2000). Ibuprofen, inflammation and Alzheimer's disease. Nat. Med. 6, 973-974.
97. Xia, X. M., Fakler, B., Rivard, A., Wayman, G., Johnson-Pais, T., Keen, J. E., et al. (1998). Mechanism of calcium gating in small-conductance calcium-activated potassium channels. Nature 395, 503-507.
98. Yan, Q., Zhang, J., Liu, H., Babu-Khan, S., Vassar, R., Biere, A. L., et al. (2003). Anti-inflammatory drug therapy alters beta-amyloid processing and deposition in an animal model of Alzheimer's disease. J. Neurosci. 23, 7504-7509.
99. Yanovsky, Y., Zhang, W., and Misgeld, U. (2005). Two pathways for the activation of small-conductance potassium channels in neurons of substantia nigra pars reticulata. Neuroscience 136, 1027-1036.
100. Zhou, F., Yao, H. H., Wu, J. Y Ding, J. H., Sun, T., and Hu, G. (2008). Opening of microglia KATP channels inhibits rotenone-induced neuroinflammation. J. Cell. Mol. Med. 12, 1559-1570.